- Home
- PRAX vs HTB Comparison
PRAX vs HTB Comparison
Compare PRAX & HTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- HTB
- Stock Information
- Founded
- PRAX 2015
- HTB 1926
- Country
- PRAX United States
- HTB United States
- Employees
- PRAX N/A
- HTB N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- HTB
- Sector
- PRAX Health Care
- HTB
- Exchange
- PRAX Nasdaq
- HTB NYSE
- Market Cap
- PRAX 599.7M
- HTB 621.7M
- IPO Year
- PRAX 2020
- HTB N/A
- Fundamental
- Price
- PRAX $38.55
- HTB $36.04
- Analyst Decision
- PRAX Strong Buy
- HTB Buy
- Analyst Count
- PRAX 10
- HTB 1
- Target Price
- PRAX $116.50
- HTB $43.00
- AVG Volume (30 Days)
- PRAX 320.6K
- HTB 38.8K
- Earning Date
- PRAX 05-02-2025
- HTB 07-23-2025
- Dividend Yield
- PRAX N/A
- HTB 0.67%
- EPS Growth
- PRAX N/A
- HTB N/A
- EPS
- PRAX N/A
- HTB 3.16
- Revenue
- PRAX $8,122,000.00
- HTB $193,954,000.00
- Revenue This Year
- PRAX N/A
- HTB $6.54
- Revenue Next Year
- PRAX N/A
- HTB $1.75
- P/E Ratio
- PRAX N/A
- HTB $11.42
- Revenue Growth
- PRAX 270.02
- HTB 0.68
- 52 Week Low
- PRAX $26.70
- HTB $30.95
- 52 Week High
- PRAX $91.83
- HTB $37.20
- Technical
- Relative Strength Index (RSI)
- PRAX 53.72
- HTB N/A
- Support Level
- PRAX $35.21
- HTB N/A
- Resistance Level
- PRAX $38.90
- HTB N/A
- Average True Range (ATR)
- PRAX 2.09
- HTB 0.00
- MACD
- PRAX 0.07
- HTB 0.00
- Stochastic Oscillator
- PRAX 69.58
- HTB 0.00
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About HTB HOMETRUST BANCSHARES INC
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.